By using this site, you agree to the IDC Privacy Policy

Dec 2015 - Business Strategy - Doc # US40704914

Business Strategy: From Product to Solution — eClinical Focuses on Delivering Outcomes in Clinical Trials

Author: Alan S. Louie, Ph.D. Research Director, Life Sciences
Abstract

This IDC Health Insights report highlights the ongoing transition from the use of individual eClinical applications to the use of more comprehensive eClinical platforms solutions in the life science industry. The increased focus on operational excellence, business agility, and business outcomes combined with the rise of SaaS, PaaS, and BPO is increasingly enabling life science companies of all sizes and foci to increasingly access comprehensive eClinical platform and service capabilities on demand.

"Depending on the life science sponsor company needs, 'best of breed' or 'solid and good enough' comprehensive eClinical platforms or services are becoming increasingly available with capabilities and features evolving along with changing industry needs. From a process perspective in clinical trials, operational excellence is at hand today," says Alan S. Louie, research director, IDC Health Insights.

Coverage
Subscriptions Covered

IDC Health Insights: Life Science Research and Development Strategy and Technology Prepublished Document Sale

Companies Covered

Oracle Corporation, PAREXEL International Corporation, SIEBEL SYSTEMS, INC., Accenture plc, Medidata Solutions, Inc., ArisGlobal., BioClinica, Inc.

Regions Covered

United States

Topics Covered

Data access, analysis and delivery, Platform as a service, Search and discovery, Software as a service

Vertical Markets

Health, Health delivery strategies

Referencing Documents
Related Links